Elanco Animal Health Inc 5EA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Elanco Animal Health Receives Emergency FDA Approval for Screwworm Prevention Spray
-
Elanco Animal Health Gets FDA, EPA Emergency Authorizations for Screwworm Treatments
-
Elanco Animal Health Gets USDA Approval for Canine-Dermatitis Treatment
-
Elanco Animal Health Obtains FDA Authorization for Screwworm Treatment
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 499.62M
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 21.91
- Price/Sales
- 2.31
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 9,900
- Website
- https://www.elanco.com
Competitors
Valuation
|
Metric
|
5EA
|
ZTS
|
MRK
|
|---|---|---|---|
Price/Earnings (Normalized) | 21.91 | 12.31 | 45.26 |
Price/Book Value | 1.72 | 10.66 | 8.55 |
Price/Sales | 2.31 | 3.67 | 5.42 |
Price/Cash Flow | 20.28 | 10.88 | 16.27 |
Price/Earnings
5EA
ZTS
MRK
Financial Strength
|
Metric
|
5EA
|
ZTS
|
MRK
|
|---|---|---|---|
Quick Ratio | 0.91 | 1.57 | 0.71 |
Current Ratio | 2.05 | 3.08 | 1.32 |
Interest Coverage | 0.33 | 14.29 | 4.28 |
Quick Ratio
5EA
ZTS
MRK
Profitability
|
Metric
|
5EA
|
ZTS
|
MRK
|
|---|---|---|---|
Return on Assets (Normalized) | 3.97% | 18.78% | 6.27% |
Return on Equity (Normalized) | 8.08% | 70.42% | 16.68% |
Return on Invested Capital (Normalized) | 6.86% | 23.70% | 9.82% |
Return on Assets
5EA
ZTS
MRK
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|<^#T&f> | LOCK|@T>x | $70B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|zyVZy&% | LOCK|fncD$ | $46B | |||
| Haleon PLC ADR
HLN
| LOCK|MrT&srK | LOCK|@MB | $45B | |||
| Zoetis Inc Class A
ZTS
| LOCK|lFHTd%R! | LOCK|?@ | $33B | |||
| Viatris Inc
VTRS
| LOCK|<f@P&Cd | LOCK|%@# | $21B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|?Dz | LOCK|QyW | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|mV>$rf! | LOCK|#C | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|j@b$G$ | LOCK|FF | $6B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|$JXm&r | LOCK|&DSj | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|^!Nk^^ | LOCK|%V | $2B |
United States